Niclosamide for Mild to Moderate COVID-19

Condition:   COVID (SARS-CoV-2) Interventions:   Drug: Niclosamide;   Drug: Placebo;   Other: Telehealth monitoring Sponsor:   Tufts Medical Center Not yet recruiting

Source: ClinicalTrials.gov - May 25, 2020 Category: Research Source Type: clinical trials